Skip to main content
Erschienen in: Journal of Neurology 6/2018

23.04.2018 | Original Communication

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease

verfasst von: Noelle E. Carlozzi, Nicholas R. Boileau, Joel S. Perlmutter, Kelvin L. Chou, Julie C. Stout, Jane S. Paulsen, Michael K. McCormack, David Cella, Martha A. Nance, Jin-Shei Lai, Praveen Dayalu

Erschienen in: Journal of Neurology | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Clinician-rated measures of functioning are often used as primary endpoints in clinical trials and other behavioral research in Huntington disease. As study costs for clinician-rated assessments are not always feasible, there is a question of whether patient self-report of commonly used clinician-rated measures may serve as acceptable alternatives in low risk behavioral trials.

Aim

The purpose of this paper was to determine the level of agreement between self-report and clinician-ratings of commonly used functional assessment measures in Huntington disease.

Design

486 participants with premanifest or manifest Huntington disease were examined. Total Functional Capacity, Functional Assessment, and Independence Scale assessments from the Unified Huntington Disease Rating scale were completed by clinicians; a self-report version was also completed by individuals with Huntington disease. Cronbach’s α was used to examine internal consistency, one-way analysis of variance was used to examine group differences, and paired t tests, kappa agreement coefficients, and intra-class correlations were calculated to determine agreement between raters.

Results

Internal consistency for self-reported ratings of functional capacity and ability were good. There were significant differences between those with premanifest, early-, and late-stage disease; those with later-stage disease reported less ability and independence than the other clinical groups. Although self-report ratings were not a perfect match with associated clinician-rated measures, differences were small. Cutoffs for achieving specified levels of agreement are provided.

Conclusions

Depending on the acceptable margin of error in a study, self-reported administration of these functional assessments may be appropriate when clinician-related assessments are not feasible.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Ross CA et al (1997) Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine (Baltim) 76(5):305–338CrossRef Ross CA et al (1997) Huntington disease and the related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine (Baltim) 76(5):305–338CrossRef
5.
Zurück zum Zitat Tabrizi SJ et al (2012) Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11(1):42–53CrossRefPubMed Tabrizi SJ et al (2012) Potential endpoints for clinical trials in premanifest and early Huntington’s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11(1):42–53CrossRefPubMed
6.
Zurück zum Zitat Frank SA et al (2004) Functional decline due to chorea in Huntington’s disease. Neurology 62(7, Suppl. 5):A204 Frank SA et al (2004) Functional decline due to chorea in Huntington’s disease. Neurology 62(7, Suppl. 5):A204
7.
Zurück zum Zitat van Vugt JP et al (2001) Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington’s disease. Mov Disord 16(3):481–488CrossRefPubMed van Vugt JP et al (2001) Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington’s disease. Mov Disord 16(3):481–488CrossRefPubMed
9.
Zurück zum Zitat Van Walsem MR et al (2017) Health-related quality of life and unmet healthcare needs in Huntington’s disease. Health Qual Life Outcomes 15(6):1–10 Van Walsem MR et al (2017) Health-related quality of life and unmet healthcare needs in Huntington’s disease. Health Qual Life Outcomes 15(6):1–10
11.
Zurück zum Zitat Huntington Study Group (1996) Unified Huntington’s Disease Rating Scale: reliability and consistency. Mov Disord 11(2):136–142CrossRef Huntington Study Group (1996) Unified Huntington’s Disease Rating Scale: reliability and consistency. Mov Disord 11(2):136–142CrossRef
12.
Zurück zum Zitat Klempir J et al (2006) Unified Huntington’s disease rating scale: clinical practice and a critical approach. Funct Neurol 21(4):217–221PubMed Klempir J et al (2006) Unified Huntington’s disease rating scale: clinical practice and a critical approach. Funct Neurol 21(4):217–221PubMed
13.
Zurück zum Zitat Huntington Study Group (2001) A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease. Neurology 57(3):397–404 Huntington Study Group (2001) A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease. Neurology 57(3):397–404
14.
Zurück zum Zitat Huntington Study Group (2006) Tetrabenazine as antichorea therapy in Huntington disease. Neurology 66(3):366–372CrossRef Huntington Study Group (2006) Tetrabenazine as antichorea therapy in Huntington disease. Neurology 66(3):366–372CrossRef
15.
Zurück zum Zitat Landwehrmeyer B et al (2007) Riluzole in Huntington’s disease: a 3-year, randomized controlled study. Ann Neurol 62:262–272CrossRefPubMed Landwehrmeyer B et al (2007) Riluzole in Huntington’s disease: a 3-year, randomized controlled study. Ann Neurol 62:262–272CrossRefPubMed
16.
Zurück zum Zitat Dishman R, Washburn R, Schoeller D (2001) Measurement of physical activity. QUEST 53:295–309CrossRef Dishman R, Washburn R, Schoeller D (2001) Measurement of physical activity. QUEST 53:295–309CrossRef
17.
Zurück zum Zitat Paulhus DL, Vazire S (2007) The self-report method. In: Robins RW, Fraley RC, Krueger RF (eds.) Handbook of research methods in personality psychology. Guilford Press, New York, NY, US, pp 224–239 Paulhus DL, Vazire S (2007) The self-report method. In: Robins RW, Fraley RC, Krueger RF (eds.) Handbook of research methods in personality psychology. Guilford Press, New York, NY, US, pp 224–239
18.
Zurück zum Zitat Cella DF (1995) Measuring quality of life in palliative care. Semin Oncol 22(2 Suppl 3):73–81PubMed Cella DF (1995) Measuring quality of life in palliative care. Semin Oncol 22(2 Suppl 3):73–81PubMed
19.
Zurück zum Zitat World Health Organization (1946) Preamble to the Constitution of WHO as adopted by the International Health Conference, New York, 19 June–22 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of WHO, no. 2, p. 100) and entered into force on 7 April 1948 World Health Organization (1946) Preamble to the Constitution of WHO as adopted by the International Health Conference, New York, 19 June–22 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of WHO, no. 2, p. 100) and entered into force on 7 April 1948
20.
Zurück zum Zitat US Department of Health and Human Services: Food and Drug Administration (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79CrossRef US Department of Health and Human Services: Food and Drug Administration (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79CrossRef
21.
Zurück zum Zitat Carlozzi NE, Tulsky DS (2013) Identification of health-related quality of life (HRQOL) issues relevant to individuals with HD. J Health Psychol 18(2):212–225CrossRefPubMed Carlozzi NE, Tulsky DS (2013) Identification of health-related quality of life (HRQOL) issues relevant to individuals with HD. J Health Psychol 18(2):212–225CrossRefPubMed
22.
Zurück zum Zitat Stout JC et al (2012) Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington’s disease. J Neurol Neurosurg Psychiatry 83(7):687–694CrossRefPubMedPubMedCentral Stout JC et al (2012) Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington’s disease. J Neurol Neurosurg Psychiatry 83(7):687–694CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Tabrizi SJ et al (2009) Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8(9):791–801CrossRefPubMedPubMedCentral Tabrizi SJ et al (2009) Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 8(9):791–801CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Tabrizi SJ et al (2011) Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10(1):31–42CrossRefPubMed Tabrizi SJ et al (2011) Biological and clinical changes in premanifest and early stage Huntington’s disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10(1):31–42CrossRefPubMed
26.
Zurück zum Zitat Hoth KF et al (2007) Patients with Huntington’s disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol 29(4):365–376CrossRefPubMed Hoth KF et al (2007) Patients with Huntington’s disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol 29(4):365–376CrossRefPubMed
27.
Zurück zum Zitat Sitek EJ et al (2012) Poor insight into memory impairment in patients with Huntington disease. Neurol Neurochir Pol 46(4):318–325PubMed Sitek EJ et al (2012) Poor insight into memory impairment in patients with Huntington disease. Neurol Neurochir Pol 46(4):318–325PubMed
28.
Zurück zum Zitat Sitek EJ et al (2013) Self-awareness of executive dysfunction in Huntington’s disease: comparison with Parkinson’s disease and cervical dystonia. Psychiatry Clin Neurosci 67(1):59–62CrossRefPubMed Sitek EJ et al (2013) Self-awareness of executive dysfunction in Huntington’s disease: comparison with Parkinson’s disease and cervical dystonia. Psychiatry Clin Neurosci 67(1):59–62CrossRefPubMed
29.
Zurück zum Zitat Sitek EJ et al (2011) Self-awareness of motor dysfunction in patients with Huntington’s disease in comparison to Parkinson’s disease and cervical dystonia. J Int Neuropsychol Soc 17(5):788–795CrossRefPubMed Sitek EJ et al (2011) Self-awareness of motor dysfunction in patients with Huntington’s disease in comparison to Parkinson’s disease and cervical dystonia. J Int Neuropsychol Soc 17(5):788–795CrossRefPubMed
30.
Zurück zum Zitat Snowden JS et al (1998) Awareness of involuntary movements in Huntington disease. Arch Neurol 55(6):801–805CrossRefPubMed Snowden JS et al (1998) Awareness of involuntary movements in Huntington disease. Arch Neurol 55(6):801–805CrossRefPubMed
31.
Zurück zum Zitat Vitale C et al (2001) Unawareness of dyskinesias in Parkinson’s and Huntington’s diseases. Neurol Sci 22(1):105–106CrossRefPubMed Vitale C et al (2001) Unawareness of dyskinesias in Parkinson’s and Huntington’s diseases. Neurol Sci 22(1):105–106CrossRefPubMed
32.
Zurück zum Zitat Stuart AL et al (2014) Comparison of self-report and structured clinical interview in the identification of depression. Compr Psychiatry 55(4):866–869CrossRefPubMed Stuart AL et al (2014) Comparison of self-report and structured clinical interview in the identification of depression. Compr Psychiatry 55(4):866–869CrossRefPubMed
33.
34.
Zurück zum Zitat Laferton JAC et al (2017) Screening for DSM-5 somatic symptom disorder: diagnostic accuracy of self-report measures within a population sample. Psychosom Med 79(9):974–981CrossRefPubMed Laferton JAC et al (2017) Screening for DSM-5 somatic symptom disorder: diagnostic accuracy of self-report measures within a population sample. Psychosom Med 79(9):974–981CrossRefPubMed
35.
36.
Zurück zum Zitat Silverstein MJ et al (2017) How informative are self-reported adult attention-deficit/hyperactivity disorder symptoms? An examination of the agreement between the adult attention-deficit/hyperactivity disorder self-report scale V1.1 and adult attention-deficit/hyperactivity disorder investigator symptom rating scale. J Child Adolesc Psychopharmacol. https://doi.org/10.1089/cap.2017.0082 PubMedCrossRef Silverstein MJ et al (2017) How informative are self-reported adult attention-deficit/hyperactivity disorder symptoms? An examination of the agreement between the adult attention-deficit/hyperactivity disorder self-report scale V1.1 and adult attention-deficit/hyperactivity disorder investigator symptom rating scale. J Child Adolesc Psychopharmacol. https://​doi.​org/​10.​1089/​cap.​2017.​0082 PubMedCrossRef
37.
Zurück zum Zitat Videm V et al (2017) Self-reported diagnosis of rheumatoid arthritis or ankylosing spondylitis has low accuracy: data from the Nord-Trondelag health study. J Rheumatol 44(8):1134–1141CrossRefPubMed Videm V et al (2017) Self-reported diagnosis of rheumatoid arthritis or ankylosing spondylitis has low accuracy: data from the Nord-Trondelag health study. J Rheumatol 44(8):1134–1141CrossRefPubMed
38.
Zurück zum Zitat Russo AC, Fingerhut EC (2017) Consistency of self-reported neurocognitive symptoms, post-traumatic stress disorder symptoms, and concussive events from end of first deployment to Veteran Health Administration Comprehensive Traumatic Brain Injury Evaluation by Operations Enduring Freedom/Iraqi Freedom/New Dawn Veterans. Arch Clin Neuropsychol 32(2):184–197PubMed Russo AC, Fingerhut EC (2017) Consistency of self-reported neurocognitive symptoms, post-traumatic stress disorder symptoms, and concussive events from end of first deployment to Veteran Health Administration Comprehensive Traumatic Brain Injury Evaluation by Operations Enduring Freedom/Iraqi Freedom/New Dawn Veterans. Arch Clin Neuropsychol 32(2):184–197PubMed
39.
Zurück zum Zitat DeViva JC, Bloem WD (2003) Symptom exaggeration and compensation seeking among combat veterans with posttraumatic stress disorder. J Trauma Stress 16(5):503–507CrossRefPubMed DeViva JC, Bloem WD (2003) Symptom exaggeration and compensation seeking among combat veterans with posttraumatic stress disorder. J Trauma Stress 16(5):503–507CrossRefPubMed
40.
Zurück zum Zitat Rohling ML, Allen LM, Green P (2002) Who is exaggerating cognitive impairment and who is not? CNS Spectr 7(5):387–395CrossRefPubMed Rohling ML, Allen LM, Green P (2002) Who is exaggerating cognitive impairment and who is not? CNS Spectr 7(5):387–395CrossRefPubMed
41.
Zurück zum Zitat Krebber AM et al (2014) Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology 23(2):121–130CrossRefPubMed Krebber AM et al (2014) Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology 23(2):121–130CrossRefPubMed
42.
Zurück zum Zitat Hamood R et al (2016) A feasibility study to assess the validity of administrative data sources and self-reported information of breast cancer survivors. Isr J Health Policy Res 5:50CrossRefPubMedPubMedCentral Hamood R et al (2016) A feasibility study to assess the validity of administrative data sources and self-reported information of breast cancer survivors. Isr J Health Policy Res 5:50CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Lo T et al (2016) Discordance between self-reported arthritis and musculoskeletal signs and symptoms in older women. BMC Musculoskelet Disord 17(1):494CrossRefPubMedPubMedCentral Lo T et al (2016) Discordance between self-reported arthritis and musculoskeletal signs and symptoms in older women. BMC Musculoskelet Disord 17(1):494CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Nazem S et al (2016) Actigraphic and sleep diary measures in Veterans with traumatic brain injury: discrepancy in selected sleep parameters. J Head Trauma Rehabil 31(2):136–146CrossRefPubMed Nazem S et al (2016) Actigraphic and sleep diary measures in Veterans with traumatic brain injury: discrepancy in selected sleep parameters. J Head Trauma Rehabil 31(2):136–146CrossRefPubMed
47.
Zurück zum Zitat Shiffman S, Stone AA, Hufford MR (2008) Ecological momentary assessment. Annu Rev Clin Psychol 4:1–32CrossRefPubMed Shiffman S, Stone AA, Hufford MR (2008) Ecological momentary assessment. Annu Rev Clin Psychol 4:1–32CrossRefPubMed
48.
Zurück zum Zitat Van den Bergh O, Walentynowicz M (2016) Accuracy and bias in retrospective symptom reporting. Curr Opin Psychiatry 29(5):302–308CrossRefPubMed Van den Bergh O, Walentynowicz M (2016) Accuracy and bias in retrospective symptom reporting. Curr Opin Psychiatry 29(5):302–308CrossRefPubMed
49.
Zurück zum Zitat Marder K et al (2000) Rate of functional decline in Huntington’s disease. Neurology 54(2):452CrossRefPubMed Marder K et al (2000) Rate of functional decline in Huntington’s disease. Neurology 54(2):452CrossRefPubMed
50.
Zurück zum Zitat Carlozzi NE et al (2016) HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD). Qual Life Res 25(10):2441–2455CrossRefPubMedPubMedCentral Carlozzi NE et al (2016) HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD). Qual Life Res 25(10):2441–2455CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Hanauer DA et al (2015) Supporting information retrieval from electronic health records: a report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). J Biomed Inform 55:290–300CrossRefPubMedPubMedCentral Hanauer DA et al (2015) Supporting information retrieval from electronic health records: a report of University of Michigan’s nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE). J Biomed Inform 55:290–300CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Paulsen JS et al (2006) Preparing for preventive clinical trials—the Predict-HD study. Arch Neurol 63(6):883–890CrossRefPubMed Paulsen JS et al (2006) Preparing for preventive clinical trials—the Predict-HD study. Arch Neurol 63(6):883–890CrossRefPubMed
53.
Zurück zum Zitat Zhang Y et al (2011) Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 156(7):751–763CrossRefPubMedCentral Zhang Y et al (2011) Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 156(7):751–763CrossRefPubMedCentral
54.
Zurück zum Zitat SAS Institute (2013) SAS 9.4 language reference concepts. SAS Institute, Cary SAS Institute (2013) SAS 9.4 language reference concepts. SAS Institute, Cary
55.
Zurück zum Zitat SPSS Inc (2013) IBM SPSS statistics for windows. Released 2013. IBM Corp., Armonk SPSS Inc (2013) IBM SPSS statistics for windows. Released 2013. IBM Corp., Armonk
56.
Zurück zum Zitat Cronbach LG (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334CrossRef Cronbach LG (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334CrossRef
57.
Zurück zum Zitat Feldt LS (1980) A test of hypothesis that Cronbach’s alpha coefficient is the same for two tests administered to the same sample. Psychometrika 49:99–105CrossRef Feldt LS (1980) A test of hypothesis that Cronbach’s alpha coefficient is the same for two tests administered to the same sample. Psychometrika 49:99–105CrossRef
58.
Zurück zum Zitat Dunn OJ (1961) Multiple comparisons among means. J Am Stat Assoc 56(293):52–64CrossRef Dunn OJ (1961) Multiple comparisons among means. J Am Stat Assoc 56(293):52–64CrossRef
59.
Zurück zum Zitat Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):10CrossRef Cohen J (1960) A coefficient of agreement for nominal scales. Educ Psychol Meas 20(1):10CrossRef
60.
Zurück zum Zitat McHugh M (2012) Interrater reliability: the kappa statistic. Biochem Med 22(3):7 McHugh M (2012) Interrater reliability: the kappa statistic. Biochem Med 22(3):7
61.
Zurück zum Zitat Nunnally J, Bernstein I (1994) Psychometric theory. McGraw-Hill, New York Nunnally J, Bernstein I (1994) Psychometric theory. McGraw-Hill, New York
62.
Zurück zum Zitat Travessa AM et al (2017) Fifteen years of clinical trials in Huntington’s disease: a very low clinical drug development success rate. J Huntingt Dis 6(2):157–163CrossRef Travessa AM et al (2017) Fifteen years of clinical trials in Huntington’s disease: a very low clinical drug development success rate. J Huntingt Dis 6(2):157–163CrossRef
64.
Zurück zum Zitat Deckel AW, Morrison D (1996) Evidence of a neurologically based “denial of illness” in patients with Huntington’s disease. Arch Clin Neuropsychol 11(4):295–302CrossRefPubMed Deckel AW, Morrison D (1996) Evidence of a neurologically based “denial of illness” in patients with Huntington’s disease. Arch Clin Neuropsychol 11(4):295–302CrossRefPubMed
Metadaten
Titel
Agreement between clinician-rated versus patient-reported outcomes in Huntington disease
verfasst von
Noelle E. Carlozzi
Nicholas R. Boileau
Joel S. Perlmutter
Kelvin L. Chou
Julie C. Stout
Jane S. Paulsen
Michael K. McCormack
David Cella
Martha A. Nance
Jin-Shei Lai
Praveen Dayalu
Publikationsdatum
23.04.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 6/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-8852-5

Weitere Artikel der Ausgabe 6/2018

Journal of Neurology 6/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.